We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.45 | 4.30 | 4.60 | 4.45 | 4.45 | 4.45 | 287,855 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.60 | 23.73M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2024 22:13 | Alchemy You may have heard SS say many times that whilst the regulatory timeframe is a burden to entry that they endure, the plus side is it is for others too and so once Eden gets its approvals, other applicants have to go through the same arduous process. I believe I am right in saying that Eden has never had a regulatory submission rejected. The larger the regulatory footprint, the greater Eden's addressable market and therefore revenue opportunity. I guess the success lies in picking the right partners to do the job at the right margin for Eden, as well as the partner. In my opinion, we should see sales revenue escalate quite sharply now and hopefully, beyond that which Cavendish has stated. I am sure AttyG would concur with that view as AttyG has expressed that view many times of late. Eden has several institutions on board already and some may be below the declaration threshold and not visible to you and me in the list of 'Significant Shareholders'. That could be a good thing in that they are interested in Eden, but will make a bigger commitment only when Eden has achieved certain goals. US approvals may be an example, finding the right insecticide partner might be another, sales turnover of XXX might be one more. Institutions do indeed have criteria and this will vary. So as you suggest, perhaps some will only view companies once they achieve a market Cap of £100 million and stabilise there or above. | investingisatrickygame | |
18/1/2024 18:49 | I meant an update . | alchemy | |
18/1/2024 18:49 | To improve , possibly, the bullish case for myself and any fellow travellers I've some questions.Do trials that seemingly have been successful ever fail wider application in reality ? I ask brcause if they don't then the barriers to entry to compete against EDEN are vast . Vast because of the aeons it has taken us to get this far.Following posts this weekend do you think we can look forward to a post regulatory approval stage ? A stage where wide geography , long list of product offerings treats us well ? This question has been carefully answered by "investing is a risky business" over the weekend . It's an ongoing process. However we now have sufficient approval to see some wealth and some happiness . I do know some AIM stocks have thrived though I've never been in them. I've been in the losers. All talk of success turns to ARM. I think a number of other stocks have gone from 20 p or so to £2 odd - Oxford Biomedica, a hydrogen focused stock whose name has gone , ITM? - which others folks?Anything I write here is of little by which I mean nil significance to the share price break out I devoutly hope for.Institutions buying I think may be key . I have read they have yardsticks , criteria , to be met before they buy.These include visible revenue , cash generation. £100 million turnover and so on.Are we on any institutions ' radar and what will they be looking for and when will we provide it? Multiple question there! And an observation to end with , Warren Buffett wittily said "put your eggs in one basket and watch the basket carefully" . That's where I'm at .I await the update ! | alchemy | |
18/1/2024 17:53 | Who is this criminal mastermind with all these fake ids? | kittybiscuits | |
18/1/2024 16:49 | You are so wrong! | money never sleeps | |
18/1/2024 16:10 | Given the immense progress Eden has made with regulatory approvals in the last 12-18 months it is almost the last chance saloon for anyone wishing to knock Eden's prospects. The knockers will be buying in spades soon enough. It has of course been a long and costly path for this small 'challenger' company (with many a fundraise needed along the way!) to reach this point of fulfilment. Plenty of other companies have fallen by the wayside trying to do the same. Hats off to the Board | money never sleeps | |
18/1/2024 13:39 | Neuts, Please stop being a moron. I am not Kitty, I am not anyone else on this or any other bulletin board. Right now, I could not care if EDEN goes to zero or twenty pence it does not change my life in any way. If by some miracle or accident it goes significantly higher, then maybe it makes a difference. My biggest loss in recent years is POLYMETAL - that also has not changed my life in any way. Whether there are multiple users on this board, I don't know, and I don't care. Rav, what price would you buy at for a speculative punt? | timbo_slice | |
18/1/2024 13:02 | As I thought, you are just untrustworthy individuals who cannot answer a simple question for fear of exposing their own deceit. | money never sleeps | |
18/1/2024 12:45 | Yap yap yap. Why don’t you answer the question you have been asked? | kittybiscuits | |
18/1/2024 11:14 | ravenna and Neutral POV - There is no balance whatsoever in any of your posts. Genuine investors should be very wary of anyone claiming to be able to crystal ball gaze as you both do (people who do that end up eating shattered glass). But since you are so VERY sure of yourselves please tell us all here what you think Eden's annual sales revenue will be for fy2023e. You can give us an indicated range if you like. I feel equally sure you won't be able to do this as it will damage your "credibility". | money never sleeps | |
18/1/2024 11:14 | Consistency is the virtue of a pudding Oscar Wilde | alchemy | |
18/1/2024 11:13 | I'm just noting in 2022 it was in March . | alchemy | |
18/1/2024 11:02 | Oh, and if you were not aware, Eden have recently changed their auditor. They have also changed their broker, twice, in as many years. Consistency, stability, reliability. NO. | ravenna23 | |
18/1/2024 10:58 | For all you newbies that invested recently via EIS schemes, Tricky is a paid poster who inserts meaningless guff when the comments about Eden are negative. Beware | ravenna23 | |
18/1/2024 10:43 | Still here tricky? How much are you paid to pump Eden? Trading update, more like disaster warning SOON | ravenna23 | |
18/1/2024 10:42 | Nothing. All 43 of you are just 2 natural persons, one an employed and sadistic ramper, the other a very stupid senile frustrated bull. "investing" = "money never sleeps" is the latter. | neutralpov | |
18/1/2024 10:35 | Alchemy, What makes you think the Trading Update is to be delivered in March? | investingisatrickygame | |
18/1/2024 10:28 | 2022 update on March I note. | alchemy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions